Atlas provides services across all phases of clinical development and has therapeutic experience in oncology, hematology, endocrinology, cardiovascular, anesthesiology, infectious diseases and the central nervous system. The firm also provides clinical trial-related services from study planning and feasibility, through site selection, data management and medical writing. Atlas also provides regulatory services and can support product registration.
Atlas has 35 employees and is headquartered in Istanbul, with additional offices in Ankara and Izmir. The business will be integrated into Parexel's Clinical Research Services business. Previously, Atlas was privately owned. The acquisition was funded with existing cash.